Agenus (AGEN)
(Delayed Data from NSDQ)
$4.68 USD
+0.02 (0.43%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $4.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Agenus (AGEN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$10.25 | $18.00 | $7.00 | 119.96% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Agenus comes to $10.25. The forecasts range from a low of $7.00 to a high of $18.00. The average price target represents an increase of 119.96% from the last closing price of $4.66.
Analyst Price Targets (4 )
Broker Rating
Agenus currently has an average brokerage recommendation (ABR) of 2.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.60 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, one is Strong Buy, representing 20% of all recommendations. A month ago, Strong Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.60 | 2.60 | 2.60 | 2.60 | 2.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | B. Riley Securities | Mayank Mamtani | Strong Buy | Strong Buy |
7/19/2024 | Robert W. Baird & Co. | Colleen M Kusy | Strong Buy | Hold |
7/18/2024 | H.C. Wainwright & Co. | Emily Bodnar | Strong Buy | Hold |
7/18/2024 | William Blair | Matt Phipps | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.60 |
ABR (Last week) | 2.60 |
# of Recs in ABR | 5 |
Average Target Price | $10.25 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | -2.30 |
AGEN FAQs
Agenus Inc. (AGEN) currently has an average brokerage recommendation (ABR) of 2.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Agenus Inc. (AGEN) is $10.25. The current on short-term price targets is based on 3 reports.
The forecasts for Agenus Inc. (AGEN) range from a low of $7 to a high of $18. The average price target represents a increase of $119.96 from the last closing price of $4.66.
The current UPSIDE for Agenus Inc. (AGEN) is 119.96%
Based on short-term price targets offered by four analysts, the average price target for Agenus comes to $10.25. The forecasts range from a low of $7.00 to a high of $18.00. The average price target represents an increase of 119.96% from the last closing price of $4.66.